Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
8
×
national blog main
national top stories
spark therapeutics
8
×
boston blog main
boston top stories
gene therapy
new york blog main
san francisco blog main
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
pfizer
roche
deals
novartis
alnylam pharmaceuticals
amgen
car-t
cell therapy
cystic fibrosis
What
bio
roundup
drug
gene
patients
therapy
aren’t
car
crispr
drugs
fda
market
payers
science
access
acquisitions
advanced
advantages
ahead
albert
american
annual
arena’s
asco
ash
bar
biggest
blood
borne
bounty
bourla
branded
brings
cancers
capacity
cell
ceo
choices
cig
comeback
Language
unset
unknown
Current search:
national
×
" spark therapeutics "
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”